retatrutide used for vs. Tirzepatide: The New Contender vs. the Current Leader Retatrutide vs Tirzepatide vs Semaglutide

NYHA, New York Heart Association

Uddin, Jixing Shen, Ebin Johny, Awishi Mondal, Jonathan Florentin, Liqun Lei, Aleef Mannan, Krithika Sudhakar Rao, John Sembrat, Mauricio Rojas, Ian Sipula, Jake Kastroll, Michael J

Lillys oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial

Step 2: Meet your medical provider Within 24 to 72 hours, a licensed clinician trained in obesity medicine reviews your intake form, decides whether labs are needed, and builds a treatment plan tailored to your biology

Regular monitoring of heart rate and blood pressure is advisable during Wegovy treatment, particularly during dose escalation phases

Heart rate variability in obesity and the effect of weight loss